LongeVC managing partner Sergey Jakimov joined the latest episode of a leading biotech podcast, Beyond Biotech, to address one of the sector's most pressing challenges: the rise of health misinformation and its consequences for both public health and the broader biotech ecosystem.
Sergey offers a candid look at how influencer-driven health narratives and unsubstantiated longevity claims are eroding public trust in evidence-based science, making it harder for credible biotech companies to communicate their work and attract capital. He also discusses the downstream effects on industry funding, the shared responsibility of scientists, investors, and media to raise the standard of health communication, and why he remains optimistic about the direction of translational longevity research.
Listen to the full episode here.
Sergey offers a candid look at how influencer-driven health narratives and unsubstantiated longevity claims are eroding public trust in evidence-based science, making it harder for credible biotech companies to communicate their work and attract capital. He also discusses the downstream effects on industry funding, the shared responsibility of scientists, investors, and media to raise the standard of health communication, and why he remains optimistic about the direction of translational longevity research.
Listen to the full episode here.